Pilulka's Market Expansion and Innovation

4.8 MAJOR CONTRACTUAL PARTNERS Alliance TM Healthcare BAYER BAYER PHOENIX group teva P&G PHARM S SANDOZA Novartis Division SANOFI → gsk GlaxoSmithKline UNIPHARMA Un 1. slovenská lekárnická akciová spoločnosť Pfizer Johnson & Johnson ZENTIVA MED-ART As a key player in the pharmacy and e-health segment, Pilulka is one of the few regional players with direct sales and marketing contracts (and also own pricing terms) with all major companies on the pharmaceutical market, including leading global pharmaceutical manufacturers In 2022, the Company directly cooperated with more than 700 suppliers, of which 177 were pharmaceutical companies. More than 60% of its deliveries were made directly without a commercial intermediary. Distribution companies help Pilulka to increase the time and volume flexibility of its deliveries The Company's goal is not only further domestic and international expansion, but also to improve its product portfolio by establishing cooperation with other partners from among pharmaceutical companies, suppliers of food supplements and vitamins, nutritional products, sporting goods and other By entering new markets, in particular Austria, the Company gains numerous local sourcing opportunities for the entire Pilulka Centralization of purchasing is one of the key initiatives that Pilulka intends to focus on in the coming years 16 +pilulka

View entire presentation